International Prescription Drug Parity Act

Summary

International Prescription Drug Parity Act - Amends the Federal Food, Drug, and Cosmetic Act to replace certain drug reimportation provisions with provisions requiring manufacturers of prescription drugs, or drugs containing insulin, manufactured in a State and domestically approved and then exported, or domestically approved and manufactured in a registered foreign establishment, to maintain specified shipment records, provide required labeling, and make the records available to U.S. importers. Directs the Secretary of Health and Human Services to establish related criteria to facilitate importation into the United States of such drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 9 June 1999

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 9 June 1999

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 9 June 1999

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.